Composition for predicting or diagnosing early-stage diffuse gastric cancer, comprising preparation for measuring level of pepsinogen ii

Abstract

The composition, kit and information provision method, according to an aspect of the present invention, may predict or diagnose early-stage diffuse-type gastric cancer with high sensitivity and specificity when the level of serum pepsinogen II is equal to or greater than 20 μg/L, and further, may classify the risk of early-stage diffuse-type gastric cancer in a subject on the basis of whether the level of serum pepsinogen II is equal to or greater than 20 μg/L and whether the status of Helicobacter pylori (HP) is positive, and thus, the composition, comprising a preparation capable of measuring the level of serum pepsinogen II, or, along with said preparation, a preparation capable of detecting the status of HP, the kit and the information provision method using same have an excellent effect of being capable of being usefully employed as non-invasive means which may be carried out prior to an endoscopy.

Dependencies are inferred from the claim text.